Spectrum Pharmaceutecals Inc (SPPI)

[Tartiaboy]

Thanks for such an extensive response.

In thinking about the current market cap, I believe that uncertainty and time are the major factors keeping it down. We don't know what the Rolontis market will be and the roll-out of Poziexon20 data is going to stretch out over many years. Best case we get cohort 1, 2L+ EGFRexon20 approved in the US some time in 2021. I don't think they will file until mid-next year. Then we will see a steady stream of follow-on filings. Only Rolontis has any chance of providing a revenue stream until late 2021.

I see the valuation of SPPI rising relatively slowly but steadily over the next four to five years based on current drivers.

Of course we could get a BO at any time, if the Poziexon20 data is compelling. Odds of a BO will be significantly higher next year.

I think the PPS will likely be between the current $10 and $20 in 2019 but near that higher range only if SPPI delivers a driver. I'm wondering if the MDACC Pozi + T-DM1 data at end of month will drive PPS up to mid-range-i.e. $15. We'll see.